BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28087649)

  • 1. Identification of unique essential proteins from a Mycobacterium tuberculosis F15/LAM4/KZN phage secretome library.
    Chiliza TE; Pillay M; Pillay B
    Pathog Dis; 2017 Jan; 75(1):. PubMed ID: 28087649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoscreening of the M. tuberculosis F15/LAM4/KZN secretome library against TB patients' sera identifies unique active- and latent-TB specific biomarkers.
    Chiliza TE; Pillay M; Naidoo K; Pillay B
    Tuberculosis (Edinb); 2019 Mar; 115():161-170. PubMed ID: 30948172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nosocomial transmission of the F15/LAM4/KZN genotype of Mycobacterium tuberculosis in patients on tuberculosis treatment.
    Pillay M; Sturm AW
    Int J Tuberc Lung Dis; 2010 Feb; 14(2):223-30. PubMed ID: 20074415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of potential druggable targets among hypothetical proteins of extensively drug resistant Mycobacterium tuberculosis (XDR KZN 605) through subtractive genomics approach.
    Uddin R; Siddiqui QN; Azam SS; Saima B; Wadood A
    Eur J Pharm Sci; 2018 Mar; 114():13-23. PubMed ID: 29174549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis.
    Naidoo CC; Pillay M
    Clin Microbiol Infect; 2014 Jun; 20(6):O361-9. PubMed ID: 24118525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
    Pillay M; Sturm AW
    Clin Infect Dis; 2007 Dec; 45(11):1409-14. PubMed ID: 17990220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fitness-compensatory mutations facilitate the spread of drug-resistant F15/LAM4/KZN and F28 Mycobacterium tuberculosis strains in KwaZulu-Natal, South Africa.
    Naidoo CC; Pillay M
    J Genet; 2017 Sep; 96(4):599-612. PubMed ID: 28947708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium tuberculosis strains induce strain-specific cytokine and chemokine response in pulmonary epithelial cells.
    Mvubu NE; Pillay B; McKinnon LR; Pillay M
    Cytokine; 2018 Apr; 104():53-64. PubMed ID: 29032986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome-wide subtractive approach to prioritize a hypothetical protein of XDR-Mycobacterium tuberculosis as potential drug target.
    Uddin R; Siddiqui QN; Sufian M; Azam SS; Wadood A
    Genes Genomics; 2019 Nov; 41(11):1281-1292. PubMed ID: 31388979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtractive screening with the Mycobacterium tuberculosis surface protein phage display library.
    Liu S; Han W; Sun C; Lei L; Feng X; Yan S; Diao Y; Gao Y; Zhao H; Liu Q; Yao C; Li M
    Tuberculosis (Edinb); 2011 Nov; 91(6):579-86. PubMed ID: 21900047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics tools and databases for whole genome sequence analysis of Mycobacterium tuberculosis.
    Faksri K; Tan JH; Chaiprasert A; Teo YY; Ong RT
    Infect Genet Evol; 2016 Nov; 45():359-368. PubMed ID: 27637931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion to and invasion of pulmonary epithelial cells by the F15/LAM4/KZN and Beijing strains of Mycobacterium tuberculosis.
    Ashiru OT; Pillay M; Sturm AW
    J Med Microbiol; 2010 May; 59(Pt 5):528-533. PubMed ID: 20110390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic characterization of Mycobacterium tuberculosis reveals potential targets of bostrycin.
    Yuan P; He L; Chen D; Sun Y; Ge Z; Shen D; Lu Y
    J Proteomics; 2020 Feb; 212():103576. PubMed ID: 31706025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development.
    Chae H; Shin SJ
    J Microbiol; 2018 May; 56(5):300-311. PubMed ID: 29721826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis.
    Dookie N; Sturm AW; Moodley P
    Infect Drug Resist; 2014; 7():223-8. PubMed ID: 25187730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring functional genomics for the development of novel intervention strategies against tuberculosis.
    Rachman H; Kaufmann SH
    Int J Med Microbiol; 2007 Nov; 297(7-8):559-67. PubMed ID: 17467338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An
    Kumar S; Sahu P; Jena L
    Int J Mycobacteriol; 2019; 8(3):252-261. PubMed ID: 31512601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis proteome microarray for global studies of protein function and immunogenicity.
    Deng J; Bi L; Zhou L; Guo SJ; Fleming J; Jiang HW; Zhou Y; Gu J; Zhong Q; Wang ZX; Liu Z; Deng RP; Gao J; Chen T; Li W; Wang JF; Wang X; Li H; Ge F; Zhu G; Zhang HN; Gu J; Wu FL; Zhang Z; Wang D; Hang H; Li Y; Cheng L; He X; Tao SC; Zhang XE
    Cell Rep; 2014 Dec; 9(6):2317-29. PubMed ID: 25497094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.